Case File
efta-efta01385540DOJ Data Set 10CorrespondenceEFTA Document EFTA01385540
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01385540
Pages
0
Persons
0
Integrity
Loading PDF viewer...
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
> BLT
Deutsche Bank lEil
0 SGS - Tom Sykes, BUY, close CHF2579, CHF2620 tgt, 2% upside
■ SGS is a long term outperformer. In line with the Business Services
team's late cycle view, we prefer more resilient stocks. SGS is a long-term
outperformer offering 10% TSR.
- It is a global leader in the testing and inspection field, with a CHF18bn
market cap.
■ SGS beat the market in 2007-11, suggesting relative upside in the event of
a potential downturn.
■ We forecast 8% 18E organic EBITA growth, with good optionality.
There is also potential for cyclical upside via c27% EBITA exposure to
commodities (we forecast 18E Minerals growth at 6%, up from 4%)
■ Structural growth opportunities from Consumer and Food + Agri
businesses.
■ Rock-solid balance sheet means M&A upside potential. Net
Debt/EBITDA is only 0.4x.
• Margin upside potential. We model a 50bps improvement in 18E from
commodities improvement, lower GIS provisions and procurement and
back-office gains. In 19E/20E we model a further 30bps and 20bps, with our
2020E forecast of 16.3% still shy of the company's target of at least 18%.
• SGS is not cheap at 24.6x 18E PIE, but we do not see a relative de-rating
until well into a cyclical cut in earnings.
• Catalysts: FY results 23-Jan-18, commodities related commentary on capex
and opex spend & bolt-on acquisition spend
Related DB Research:
SGS: Store of value (Sykes'
Business Services 2018 outlook: Relative outperformers for 2018 (Sykes)
SGS is a long term outperformer of the market
1.0
0.1
03
‘1
co
co
O
SGS share price relative in USD
nr
e
e
z..r
c2
OO
Expon. (SGS share price relative in USD)
O
N
Ci
pc-
•cr2
O
2
O
O O
r
r
CO
0)
O
O
CO
V
r--
O
O
O nr
Room for considerable M &A, with a rock-solid balance sheet
1.5
1.0
0.5
0.0
-0.5
-1.0
-1.5
Net debt/EBITDA
Acquisition spend as % of EBITDA
40%
30%
20%
10%
0%
-10%
-20%
-30%
-40%
AA A A
o
O
r
CA
01
V
'4)
OOOOO
O
O
la
t•
W
CO
W
ill
CO
0
C‘I
C0
Csl
N
N
N
CO
CO
IN
CI
O4
<V
O
N
CO
O4
CO
ft.Ltsche bank Research' Etinwean Equity Focus - Janistuy 2O18
4!
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e)
DB-SDNY-0086826
CONFIDENTIAL
SDNY_GM_00233010
EFTA01385540
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.